KDM4A anticorps (C-Term)
Aperçu rapide pour KDM4A anticorps (C-Term) (ABIN6952408)
Antigène
Voir toutes KDM4A AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
-
-
Épitope
- C-Term
-
Specificité
- Polyclonal antibody raised in rabbit against human JMJD2a (Jumonji domain containing 2a), using a synthetic peptide containing a sequence from the C-terminal part of the protein.
-
Réactivité croisée
- Souris
-
Purification
- Affinity purified
-
Immunogène
- synthetic peptide
-
-
-
-
Indications d'application
-
ChIP 5 μg:ChIP
WB 1:500
IP 3 μg:IP -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 μg/μL
-
Buffer
- TBS, 0,1 % BSA, 0.05 % azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
-
- KDM4A (Lysine (K)-Specific Demethylase 4A (KDM4A))
-
Autre désignation
- JMJD2a
-
Sujet
- JMJD2a (UniProtKB/Swiss-Prot entry O75164), belongs to the JMJD2 family of histone demethylases which play an important role in the establishment of the histone code. JMJD2a specifically demethylates the trimethylated K9 and K36 of histone H3, thereby converting these lysines to the dimethylated form. It has no activity towards H3K4, H3K27 and H4K20, or to the mono- and dimethylated H3K9 and H3K36. JMJD2a plays a role in the transcriptional repression of ASCL2 and E2F-responsive promoters via the recruitment of histone deacetylases and NCOR1, respectively.
-
UniProt
- O75164
-
Pathways
- L'effet Warburg
Antigène
-